Webinar Continuous Monitoring Concept - Final 1
Webinar Continuous Monitoring Concept - Final 1
Webinar Continuous Monitoring Concept - Final 1
Pharmaceutical Manufacturing
REGULATORY GUIDELINES
•
Total Particle Monitoring
TOTAL PARTICLE CONTINUOUS MONITORING:
Portable instruments or remote instruments?
“4.18 Isolators or RABS, which are different technologies, and the associated processes, should be designed to
provide protection through separation of the grade A environment from the environment of the surrounding room.
The hazards introduced from entry or removal of items during processing should be minimized and supported by high
capability transfer technologies or validated systems that robustly prevent contamination and are appropriate for the
respective technology.”
Annex1, The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use
Total Particle Monitoring
• Filling Lines
• Biosafety Cabinets
• Isolators
Viable Continuous Monitoring
• Volumetric (CFU/m3)
• Higher Cost
• System Validation in compliance with ISO
• Non-Volumetric (CFU/Plate)
• Low cost
• Exposure impact (assessment of material)
Viable Continuous Monitoring
knowledge of:
• Process inputs
• Facility equipment
• Criticality of a process
• EM Data
• ®
• ®
• ®
• ®
• ®
• ®
PMS Advisory Team
Environmental Monitoring Cleaning and Aseptic Process Sterility
Risk/Gap Analysis Disinfection Simulation Assurance
Audits
BioCapt® Single-use
FacilityPro®
Coaching
Conclusions
Environmental monitoring is one of several key elements required in order to ensure that an
aseptic processing area is maintained with an adequate level of control.
Keep under control the Contamination means to guarantee a safety product and the safety of
the final target: The Patients.
THANK YOU!
Contact us:
Sara Todisco
QUESTIONS?
Advisory Documentation Specialist
Confidential and proprietary
General: [email protected]
Personal:
[email protected]